Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
about
Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsCaspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.Posaconazole as salvage therapy for zygomycosis.Zygomycosis in Immunocompromised non-Haematological Patients.Epidemiology of invasive fungal infections in the mediterranean areaMortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009Carotid artery occlusion by rhinoorbitocerebral mucormycosis.Hyperthyroidism secondary to disseminated mucormycosis in a child with acute lymphoblastic leukemia: case report and a review of published reports.Rhinocerebral mucormycosis: literature review apropos of a rare entity.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse modelLiposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae.Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections.
P2860
Q26740363-3DAA87FC-3D36-437D-95CB-18F888620872Q33573788-93A6FD35-2ECE-4459-B758-CDF8C751E192Q33805542-CE1FEC40-23A5-44D9-B470-95ECF70FF0CFQ34301611-3CA8C94E-1A96-47D8-ADE7-19BC1F2F357BQ35010681-C4DE9FB2-58FA-4773-85BB-88865FF91E2FQ35010686-6686F572-0014-4BA8-8162-6D5E41BC6F0DQ35364288-C878041E-A446-49C6-9C5A-81212DC1BA2CQ36415074-81E2ABF0-59C6-43D3-B67D-7CD9C111E64BQ36549983-3D2F79C5-7846-401E-AA85-D0C04B3FF348Q36703586-C80490DF-B65C-4969-997A-CEEFE22200CAQ36862446-27BDA35B-09CF-4985-BB22-0298C8D19E7DQ37469829-AC31A0E6-A5B5-44C1-8127-96333E6253B8Q39652289-B122A54E-3EDB-4670-86DF-104000EE4E1EQ39913385-284B2021-7DD3-47D5-B893-C487124B08C8Q41848545-FDA0B5DC-2E0F-4866-8B29-B322ACDC615F
P2860
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@ast
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@en
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@nl
type
label
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@ast
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@en
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@nl
prefLabel
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@ast
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@en
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion.
@nl
P2093
P356
P1476
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion
@en
P2093
E J Anaissie
G A Noskin
J R Graybill
L A Pietrelli
R A Bowden
R Herbrecht
V Letscher-Bru
P2888
P304
P356
10.1007/S100960100528
P577
2001-07-01T00:00:00Z
P6179
1026675016